We harvested tumors from mice at day 13 post inoculation when there were no significant differences in tumor size and found that the numbers of NK1.1+CD3− natural killer (NK) cells, Ly6ChighLy6G− monocytes, Ly6ClowLy6Ghigh granulocytes and CD8+ T cells were not different between tumors harvested from control and TM treated mice (Fig. 5a). Here, CD8A is linked to neoplasm.